| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 25mg |
|
||
| 50mg |
|
||
| 100mg |
|
||
| 250mg |
|
||
| 500mg |
|
||
| Other Sizes |
|
Purity: ≥98%
TH287 is a potent and selective MTH1 (NUDT1) inhibitor with IC50 of 0.8 nM. TH287 selectively and efficiently kills U2OS and other cancer cell lines while being less toxic to many primary or immortalized cells, and it causes oxidative DNA damage. In U2OS and other cancer cell lines, TH287 treatment selectively and effectively kills cancer cells while being less toxic to some primary or immortalized cells. Increase in 8-oxodG in DNA is observed in U2OS cells treated with TH287. In U2OS cells, the MTH1 inhibitor TH287 causes DNA damage, activates an ATM-p53-mediated death response, and causes DNA repair.
| Targets |
MTH1 (IC50 = 0.8 nM)
|
||
|---|---|---|---|
| ln Vitro |
TH287 (1-10 μM; 24 h) selectively and efficiently destroys U2OS and other cancer cell lines, but is considerably less toxic to several primary or immortalized cells[1].
|
||
| ln Vivo |
In mice, TH287 (5 mg/kg; i.p.) has a Cmax of 0.82 M and a tmax of 0.5 h[2].
|
||
| Cell Assay |
In U2OS and other cancer cell lines, TH287 treatment selectively and effectively kill cancer cells with less toxic to some primary or immortalized cells. Increase in 8-oxodG in DNA is seen in U2OS cells treated with TH287. In U2OS cells, the MTH1 inhibitor TH287 causes DNA damage that prompts DNA repair and an ATM-p53-mediated death response.
|
||
| Animal Protocol |
|
||
| References |
|
| Molecular Formula |
C11H10CL2N4
|
|
|---|---|---|
| Molecular Weight |
269.13
|
|
| Exact Mass |
268.028
|
|
| Elemental Analysis |
C, 49.09; H, 3.75; Cl, 26.34; N, 20.82
|
|
| CAS # |
1609960-30-6
|
|
| Related CAS # |
TH287 hydrochloride;1638211-05-8
|
|
| PubChem CID |
73441664
|
|
| Appearance |
White to off-white solid powder
|
|
| Density |
1.4±0.1 g/cm3
|
|
| Boiling Point |
512.2±60.0 °C at 760 mmHg
|
|
| Flash Point |
263.5±32.9 °C
|
|
| Vapour Pressure |
0.0±1.3 mmHg at 25°C
|
|
| Index of Refraction |
1.681
|
|
| LogP |
3.48
|
|
| Hydrogen Bond Donor Count |
2
|
|
| Hydrogen Bond Acceptor Count |
4
|
|
| Rotatable Bond Count |
2
|
|
| Heavy Atom Count |
17
|
|
| Complexity |
254
|
|
| Defined Atom Stereocenter Count |
0
|
|
| SMILES |
ClC1C(=C([H])C([H])=C([H])C=1C1=C([H])C(=NC(N([H])[H])=N1)N([H])C([H])([H])[H])Cl
|
|
| InChi Key |
URWCXPXBBITYLR-UHFFFAOYSA-N
|
|
| InChi Code |
InChI=1S/C11H10Cl2N4/c1-15-9-5-8(16-11(14)17-9)6-3-2-4-7(12)10(6)13/h2-5H,1H3,(H3,14,15,16,17)
|
|
| Chemical Name |
6-(2,3-dichlorophenyl)-N4-methylpyrimidine-2,4-diamine
|
|
| Synonyms |
|
|
| HS Tariff Code |
2934.99.9001
|
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
|
|||
|---|---|---|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (9.29 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (9.29 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.7157 mL | 18.5784 mL | 37.1568 mL | |
| 5 mM | 0.7431 mL | 3.7157 mL | 7.4314 mL | |
| 10 mM | 0.3716 mL | 1.8578 mL | 3.7157 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
COA